Related Experiment Video

Updated: Jul 11, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

What's new in metabolic and genetic hypoglycaemias: diagnosis and management

Vassili Valayannopoulos1, Stéphane Romano, Karine Mention

  • 1Metabolic Department and Reference Centre for Metabolic Diseases, Necker-Enfants Malades Hospital, 149, Rue des Sèvres, 75015 Paris, France, vassili.valaya@nck.aphp.fr

European Journal of Pediatrics
|October 4, 2007
PubMed

Insights

Hypoglycaemia in children requires rigorous assessment for efficient treatment and to prevent cerebral damage. New genetic discoveries and diagnostic tests improve understanding and management of blood glucose regulation disorders.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Neuroscience

Background:

  • Hypoglycaemia in children is a critical condition requiring prompt and accurate diagnosis to prevent severe complications like cerebral damage.
  • Understanding the intricate mechanisms of blood glucose regulation is essential for diagnosing and managing hypoglycaemia.
  • Recent advancements have identified novel genetic causes and diagnostic tools for glucose homeostasis impairments.

Purpose of the Study:

  • To highlight the importance of rigorous assessment in diagnosing and managing paediatric hypoglycaemia.
  • To discuss the role of clinical history, presentation, and basic tests in identifying the cause of hypoglycaemia.
  • To introduce recent discoveries in genetic causes and advanced diagnostic technologies for hypoglycaemia.

Main Methods:

  • Review of clinical presentation and diagnostic approaches for paediatric hypoglycaemia.
  • Analysis of newly identified metabolic and endocrinologic genetic causes of hypoglycaemia.
  • Evaluation of novel diagnostic tests, including 18-fluoro-Dopa PET-scan.

Main Results:

  • Clinical evaluation combined with simple tests can diagnose most cases of paediatric hypoglycaemia.
  • Identification of new genetic factors provides deeper insight into glucose homeostasis mechanisms.
  • Advanced imaging like 18-fluoro-Dopa PET-scan offers new diagnostic capabilities.

Conclusions:

  • Effective management of paediatric hypoglycaemia relies on thorough diagnostic assessment.
  • Ongoing research into genetic causes and diagnostic methods is crucial for advancing care.
  • Early and accurate diagnosis is key to preventing long-term neurological sequelae in children with hypoglycaemia.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...